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Francisella tularensis is a highly virulent zoonotic bacterial pathogen capable of infecting numerous different
mammalian species, including humans. Elucidation of the pathogenic mechanisms of F. tularensis has been
hampered by a lack of tools to genetically manipulate this organism. Herein we describe the use of transposome
complexes to create insertion mutations in the chromosome of the F. tularensis live vaccine strain (LVS). A
Tn5-derived transposon encoding kanamycin resistance and lacking a transposase gene was complexed with
transposase enzyme and transformed directly into F. tularensis LVS by electroporation. An insertion frequency
of 2.6  108  0.87  108 per cell was consistently achieved using this method. There are 178 described Tn5
consensus target sites distributed throughout the F. tularensis genome. Twenty-two of 26 transposon insertions
analyzed were within known or predicted open reading frames, but none of these insertions was associated with
the Tn5 target site. Analysis of the insertions of sequentially passed strains indicated that the transposons were
maintained stably at the initial insertion site after more than 270 generations. Therefore, transformation by
electroporation of Tn5-based transposon-transposase complexes provided an efficient mechanism for gener-
ating random, stable chromosomal insertion mutations in F. tularensis.
Francisella tularensis is a gram-negative bacterial pathogen
and is the etiologic agent of tularemia. The manifestations of
tularemia depend on the initial route of inoculation, but all
modes of contact can result in sepsis and disseminated disease,
with organisms found in the liver, spleen, lymph nodes, kidney,
and lungs (6, 20, 24, 25). Skin contact results in ulcer formation
at the site of inoculation, where the organisms multiply and
spread to the draining lymph nodes. Inhalation of F. tula-
rensis leads to bronchial hemorrhaging, mediastinal lymph-
adenopathy (27), and pneumonia without a corresponding
productive cough. Ingestion of the organisms can result in
oropharyngeal tularemia, where patients typically develop
exudative ulcerative pharyngitis and pharyngeal lymphade-
nopathy (1, 4).
F. tularensis strains are divided into two groups, A and B,
which are distinguished by acid production from glycerol and
by citrulline ureidase activity. The two groups of organisms
exhibit similar pathogenesis; however, group A strains are con-
sidered to be highly virulent for humans and other animals,
whereas group B strains typically cause milder disease (28). A
live attenuated vaccine strain (LVS) derived from a group B F.
tularensis strain has been developed and used to vaccinate
laboratory workers (7). This vaccine provides significant pro-
tection against the highly virulent strains initiated by skin con-
tact (21) and inhalation (13, 22). However, the basis for atten-
uation of this strain in humans is not known, and it has not
been licensed for general public use in the United States.
F. tularensis can survive within macrophages, a feature that is
thought to be important in the pathogenesis of this organism
(5, 12, 17, 26). F. tularensis subsp. novicida, a related organism
historically referred to as Francisella novicida, also survives
within macrophages, but it is an animal pathogen that does not
infect humans. Two different genetic loci, termed mglAB for
macrophage growth locus (2) and iglABCD for intracellular
growth locus (11), have been identified in F. tularensis subsp.
novicida that contribute to its survival in macrophages. The
function of the igl gene products in promoting this survival has
not been determined. MglA of F. tularensis subsp. novicida has
recently been shown to function as a positive regulator for at
least seven different genes (16) that are normally induced in
macrophages, including iglC. An F. tularensis subsp. novicida
mutant lacking mglA is unable to survive in cultured macro-
phages and is attenuated in mice (16). Homologues of these
genes are present in both group A and B F. tularensis strains,
and they presumably serve similar functions in these organ-
isms.
Apart from the described macrophage survival phenotype
and the identification of a limited number of genetic loci that
contribute to intracellular survival (11), very little is known
about the molecular mechanisms that support F. tularensis
pathogenesis and virulence. The lack of tools for the genetic
manipulation of F. tularensis has made it difficult to identify
and dissect the bacterial products and processes that contrib-
ute to this organism’s extraordinary virulence and pathogene-
sis. Mechanisms of transformation and allelic exchange have
only recently been described (3, 8, 15), and most of these
procedures have been developed in F. tularensis subsp. novi-
cida. Lauriano et al. (15) recently described the use of allelic
exchange to generate targeted insertion mutations in F. tula-
rensis LVS. They also reported that Tn10- and Tn1721-based
transposon insertions were unstable in F. tularensis and that
bacterial gene-encoded transposase-complementing activity
may function to promote the movement of these transposons.
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Herein we describe a procedure that uses a Tn5 derivative to
create insertion mutations in F. tularensis LVS which, unlike
Tn10 and Tn1721, were stably maintained at the initial inser-
tion site.
F. tularensis LVS was obtained from the Centers for Disease
Control and Prevention, Atlanta, Ga., and were propagated at
37°C on chocolate medium supplemented with 1% IsoVitalex
(BBL). Multiple colonies from an overnight culture of LVS
grown on chocolate agar were picked and swabbed onto fresh
plates to achieve confluent growth, and they were then incu-
bated for 16 h. Cells from one plate of freshly confluent LVS
were suspended in 6 ml of wash buffer, consisting of 0.5 M
sucrose and 10% glycerol, and then were centrifuged at 16,000
 g for 3 min. The pellet was suspended in wash buffer and
centrifuged again for a total of four washes. The pellet result-
ing from the final centrifugation was suspended in wash buffer
to a total volume of 100 l.
A procedure initially described by Goryshin et al. (9) to
create mutations in Salmonella, Proteus, and Escherichia spe-
cies was used to produce similar transposon insertion muta-
tions in F. tularensis LVS. One microliter of EZ::TN kan-2
transposome complex (Epicentre) containing 0.1 pmol of
transposon and 1 U of transposase was added to 100 l of the
washed cell suspension, consisting of 109 to 1010 cells in 0.5 M
sucrose and 10% glycerol. The contents were then mixed and
transferred to a 0.1-cm-gap electroporation cuvette.
The EZ::TN kan-2 transposome contains a derivative of
Tn5 that lacks a transposase gene and has the transposase
enzyme bound to the inverted repeat ends of the transposon.
The transposase is stably associated with the transposon but is
inactive in the absence of Mg2. Magnesium ions present in-
side the bacterium activate the transposase following transfor-
mation, facilitating transposition into the Francisella chromo-
some. Thus, transposition is dependent simply upon activation
of the enzyme and not the expression of a foreign transposase
gene.
The transposome was introduced into F. tularensis LVS by
electroporation using a Bio-Rad Gene Pulsar set at 2.5 kV, 25
F, and 200 . Immediately following electroporation the cells
were suspended in 1 ml of brain heart infusion broth (BBL)
supplemented with 50 g of hemin/ml, incubated for 1 h at
37°C, and then plated on chocolate agar containing 10 g of
kanamycin/ml.
We consistently achieved an insertion frequency of 2.6 
108  0.87  108 (Table 1), as determined by the number of
antibiotic-resistant colonies divided by the total number of
potential recipient organisms. The insertion frequency was not
appreciably affected by the number of bacteria, nor was it
improved by increasing the concentration of transposome com-
plexes. Recovering the organisms with cold or prewarmed me-
dia following electroporation as described for other organisms
(23) also did not alter the frequency with which we isolated
antibiotic-resistant organisms.
Ideally a transposon will insert randomly throughout a ge-
nome in order to be a useful tool for creating insertion muta-
tion libraries. The transposon insertion sites were mapped by
directly sequencing the transposon-chromosome junctions by
using oligonucleotide primers that hybridize within the trans-
poson. Primers Kan-2 FP-1 (ACCTACAACAAAGCTCTCA
TCAACC) and JF119 (GGATCAGATCACGCATCTTC) hy-
bridize 70 and 150 bp, respectively, from the end of the
transposon adjacent to the 3	 end of the Kan resistance gene,
and primer KAN RP-1 (GCAATGTAACATCAGAGATTTT
GAG) hybridizes 43 bp from the other end of the transposon.
Individual kanamycin-resistant colonies were picked and re-
streaked on selective media. Chromosomal DNA was prepared
from strains by using the MasterPure DNA purification kit
according to the manufacturer’s instructions (Epicentre).
The precise transposon-chromosome junction sites were de-
termined in a total of 26 kanamycin-resistant colonies from
each of three different transformations. One microgram of
chromosomal DNA was mixed with 100 pM primer, and DNA
sequence was generated by the University of North Carolina
Genome Analysis Center. The transposon insertion site was
determined by aligning the sequence to the F. tularensis LVS
strain genome database produced by the Biology and Biotech-
nology Research Program Sequencing Group at Lawrence Liv-
ermore National Laboratory (http://bbrp.llnl.gov/bbrp/html
/microbe.html).
Tn5, the transposon upon which EZ::TN is based, has a
reported insertion bias for the sequence A-GNTYWRANC-T
(where W is A or T, R is A or G, Y is C or T, and N is any base)
(10). The F. tularensis 1.8-Mbp LVS genome has 178 of these





2.8  1010 344 1.0  108
4.9  109 62 1.2  108
1.1  109 50 4.5  108
2.6  109 207 7.0  108
5.7  1010 1,097 1.9  108
2.3  1010 550 1.0  108
1.4  1010 210 1.5  108
TABLE 2. Identified transposon insertion sites
Strain designation Predicted insertion
A1 ...............................Extragenic
A2 ...............................Deacyclase
A3 ...............................Guanosine polyphosphate pyrophosphohydrolases
A4 ...............................Hydrolase of HD superfamily
A5 ...............................Metal-dependent hydrolase
A6 ...............................Extragenic
A8 ...............................Hypothetical protein gi34496297
A9 ...............................Extragenic















C4................................Chloride channel protein EriC
C6................................Anthranilate synthase
C7................................Tryptophan synthase alpha chain
C8................................Multidrug resistance protein
C10..............................Integral membrane protein
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insertion bias sequences, but none of the 26 insertions that we
analyzed occurred within one of these sites. Of the 26 junction
sites sequenced, 21 were within potential open reading frames
and 1 was in the transcription termination sequence of an open
reading frame, which is consistent with the observation that,
apart from the Tn5 insertion bias site, this transposon has a
propensity for inserting into actively transcribed DNA and
regions of high superhelical density (18, 19). One insertion, B5,
was in a gene encoding the RNA polymerase 
 subunit; this is
an essential gene. The insertion is located 12 bases from the 3	
end of the gene. F. tularensis LVS does not possess a second
copy of this gene; thus, it is likely that the B5 mutant still
produces a functional RNA polymerase 
 subunit. Ironically,
one of the insertions (strain A10; Table 2 and Fig. 1) was
within a gene reported to encode a Francisella transposase
(14). The insertions did not appear to cluster within a specific
chromosomal segment (Fig. 1).
Insertions in potential reading frames were examined fur-
ther by translating the sequence and blasting the protein database
to tentatively identify the products of interrupted genes. The
majority, but not all, of these mutations occurred in genes that
encoded proteins with significant homology to proteins with
known functions or conserved hypothetical proteins (Table 2).
Lauriano et al. reported that insertion mutations created by
derivatives of the Tn10 and Tn1721 transposons in the closely
related organism F. tularensis subsp. novicida were unstable
and subject to movement to other chromosomal locations,
possibly through the activity of a host-encoded transposase
(15). We picked five transposon insertion mutation strains
representing insertions within and outside of potential reading
frames, including the strain with the insertion in the reported
Francisella transposase gene. These strains were passed daily
for 10 days on kanamycin-containing media, and chromosomal
DNA was prepared from cells on passages 0, 5, and 10. South-
ern blots were performed by digesting 5 g of chromosomal
DNA with EcoRI, which does not cleave the transposon. Di-
gested DNA segments were separated by agarose gel electro-
phoresis, transferred to nylon, and probed with digoxigenin-
labeled Tn5 probe. The Tn5 probe hybridized to identically
sized fragments in each of the DNA samples prepared from
different passages of the same insertion strain (Fig. 2). Given
that a single colony is composed of at least 108 organisms, a
single passage equates to at least 27 generations of growth.
Thus, after 10 passages the analyzed insertions were stable for
a minimum of 270 generations.
Electroporation of a Tn5-derived transposon-transposase
enzyme complex into F. tularensis LVS resulted in the creation
of random insertion mutant strains at a frequency that is suf-
ficient to generate mutant libraries of this organism. These
insertions are genetically stable and are apparently unaffected
by the activities of any potential chromosomally encoded trans-
posases. Thus, this scheme will facilitate the use of genetic
approaches to study the mechanisms of F. tularensis physiology
and pathogenesis.
FIG. 1. Graphic representation of the chromosomal positions of the 27 identified insertion sites. The insertions assessed for stability and
depicted in Fig. 2 are labeled.
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FIG. 2. Southern blot of five insertion mutants (A6, A10, B1, B2, B5, and C10) and wild-type F. tularensis LVS probed with labeled Tn5.
Chromosomal DNA was prepared from mutants after 0, 5, and 10 passages, digested with EcoRI, and probed. All insertions analyzed in this
manner retained the transposon at the initial insertion site.
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